Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-... — FDA record D-0029-2025

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 21, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24
Reason
Superpotent Drug: Stability failure for assay at 6 months test time-point.
Classification
Class II
Recalling firm
BLI International, Inc.
Quantity
4,901 cases/24 count each case
Agency-reported status
Terminated
Source record identifier
D-0029-2025

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityLot # 24A27724, Exp 01/31/2027

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Product was shipped to two private label customers ( OH & MO) as a final packaged product.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Nov 6, 2024
Recall initiation date
Oct 21, 2024
Center classification date
Oct 30, 2024
Termination date
Dec 5, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records